Johnson & Johnson

NYSE:JNJ   3:59:58 PM EDT
+0.76 (+0.45%)
Equity Investments, Earnings Announcements

Johnson & Johnson Says XWPharma Completes $40 Mln Financing and Appoints Leonard Blum as CEO

Published: 09/17/2020 12:30 GMT
Johnson & Johnson (JNJ) - Xwpharma - Completed a $40 Million Series C Financing.
Xwpharma - Financing Was Led by Panacea Venture, With Participation From Existing Investors, Johnson & Johnson Innovation.
Revenue is expected to be $22.52 Billion
Adjusted EPS is expected to be $2.29

Next Quarter Revenue Guidance is expected to be $23.45 Billion
Next Quarter EPS Guidance is expected to be $2.40

More details on our Analysts Page.